Abstract
More than 3170 pairs of U.S.-approved generic and brand drug names look or sound enough alike that health care workers have mixed up those medications, according to new research from the United States Pharmacopeia (USP). The research, based on more than 26,000 records in two USP-associated medication-error reporting programs for 2003–06, also found that patients might have been harmed by 1.4% of the mistakes attributed to look-alike or sound-alike drug names. Seven of the mistakes might have contributed to or resulted in death (see the table1). Given that the programs involve the voluntary reporting of mistakes, the number of mix-ups is “probably understated at best,” said USP Vice President Diane D. Cousins in a January 29 media briefing. The vast majority of the records, 26,092, came from more than 670 health care facilities participating in USP’s Medmarx program, according to the data report produced by USP. Another 512 records came from the medication-errors reporting program run by USP and the Institute for Safe Medication Practices (ISMP).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.